BGLAF (BioGaia AB) Total Stockholders Equity : $158.4 Mil (As of Sep. 2024)

View and export this data going back to 2013. Start your Free Trial

What is BioGaia AB Total Stockholders Equity?

BioGaia AB's Total Stockholders Equity for the quarter that ended in Sep. 2024 was $158.4 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. BioGaia AB's Book Value per Share for the quarter that ended in Sep. 2024 was $1.57. The ratio of a company's debt over equity can be used to measure how leveraged this company is. BioGaia AB's Debt-to-Equity for the quarter that ended in Sep. 2024 was 0.00.

BioGaia AB Total Stockholders Equity Historical Data

The historical data trend for BioGaia AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioGaia AB Total Stockholders Equity Chart

BioGaia AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

53.84

208.80

206.54

190.06

197.94

BioGaia AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Stockholders Equity	Get a 7-Day Free Trial															179.10	197.94	208.24	150.22	158.35

BioGaia AB (OTCPK:BGLAF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

BioGaia AB's Book Value per Share for the quarter that ended in Sep. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(158.354	-	0)	/	101.162
	=	1.57

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

BioGaia AB's Debt-to-Equity for the quarter that ended in Sep. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	158.354
	=	0.00

BioGaia AB Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of BioGaia AB's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

BioGaia AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioGaia AB (OTCPK:BGLAF) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

BIOG B:Sweden 0GTN:UK BGLA:Germany

Address

Kungsbroplan 3A, Stockholm, SWE, SE-112 27

Website

https://www.biogaia.se

BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.